Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Guidelines on myocardial revascularization.

Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) None., European Association for Percutaneous Cardiovascular Interventions (EAPCI) None., Kolh P., Wijns W., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli MF., Pirlet C., Pomar JL., Reifart N., Ribichini FL., Schalij MJ., Sergeant P., Serruys PW., Silber S., Sousa Uva M., Taggart D.

Original publication

DOI

10.1016/j.ejcts.2010.08.019

Type

Journal article

Journal

Eur J Cardiothorac Surg

Publication Date

09/2010

Volume

38 Suppl

Pages

S1 - S52

Keywords

Acute Disease, Arrhythmias, Cardiac, Assisted Circulation, Blood Vessel Prosthesis Implantation, Carotid Artery Diseases, Chronic Disease, Contraindications, Contrast Media, Diabetic Angiopathies, Diagnostic Imaging, Drug-Eluting Stents, Europe, Fibrinolytic Agents, Graft Rejection, Heart Failure, Heart Valve Diseases, Humans, Hypoglycemic Agents, Kidney Diseases, Myocardial Ischemia, Myocardial Revascularization, Patient Education as Topic, Platelet Aggregation Inhibitors, Postoperative Care, Preoperative Care, Prognosis, Renal Artery Obstruction, Risk Assessment, Stroke